Overview
Malignant germ cell tumor of the corpus uteri is an extremely rare neoplasm arising from germ cells located within the body (corpus) of the uterus. Germ cell tumors typically originate from primordial germ cells and are more commonly found in the ovaries or testes, but in rare instances they can develop in extragonadal sites including the uterine corpus. These tumors may include histological subtypes such as yolk sac tumor (endodermal sinus tumor), choriocarcinoma (non-gestational type), immature teratoma, embryonal carcinoma, or mixed germ cell tumors occurring within the uterine body. The ICD-10 codes C54.0 through C54.8 correspond to malignant neoplasms of different regions of the corpus uteri, including the isthmus, endometrium, myometrium, fundus, and overlapping sites. Patients may present with abnormal uterine bleeding, pelvic pain, an enlarging uterine mass, or symptoms related to advanced disease such as abdominal distension. Elevated serum tumor markers including alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH) may be observed depending on the histological subtype and can aid in diagnosis and monitoring. Due to the rarity of this condition, diagnosis often requires careful histopathological examination and immunohistochemical staining to distinguish it from more common uterine malignancies such as endometrial carcinoma or gestational trophoblastic disease. Treatment approaches are largely extrapolated from experience with ovarian germ cell tumors and typically involve surgical management, often including hysterectomy, combined with platinum-based chemotherapy regimens such as BEP (bleomycin, etoposide, and cisplatin). Prognosis varies depending on the specific histological subtype, stage at diagnosis, and response to chemotherapy. Given the extreme rarity of this tumor, management is best guided by multidisciplinary teams at specialized centers, and patients may benefit from referral to clinical trials when available.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Malignant germ cell tumor of the corpus uteri.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Malignant germ cell tumor of the corpus uteri at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Malignant germ cell tumor of the corpus uteri.
Community
No community posts yet. Be the first to share your experience with Malignant germ cell tumor of the corpus uteri.
Start the conversation →Latest news about Malignant germ cell tumor of the corpus uteri
No recent news articles for Malignant germ cell tumor of the corpus uteri.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Malignant germ cell tumor of the corpus uteri
What is Malignant germ cell tumor of the corpus uteri?
Malignant germ cell tumor of the corpus uteri is an extremely rare neoplasm arising from germ cells located within the body (corpus) of the uterus. Germ cell tumors typically originate from primordial germ cells and are more commonly found in the ovaries or testes, but in rare instances they can develop in extragonadal sites including the uterine corpus. These tumors may include histological subtypes such as yolk sac tumor (endodermal sinus tumor), choriocarcinoma (non-gestational type), immature teratoma, embryonal carcinoma, or mixed germ cell tumors occurring within the uterine body. The IC
How is Malignant germ cell tumor of the corpus uteri inherited?
Malignant germ cell tumor of the corpus uteri follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Malignant germ cell tumor of the corpus uteri?
6 specialists and care centers treating Malignant germ cell tumor of the corpus uteri are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.